robmotl-keynote ppt · exercise vs. other approaches depressive symptoms ensariet al., j...

7
10/21/2015 1 Exercise and Multiple Sclerosis: Symptom Management or Disease Modification? Robert W. Motl, PhD Professor, Department of Kinesiology and Community Health Affiliate, Neuroscience Program Chair, Institutional Review Board Disclosures 1. Speaker’s bureau for EMD Serono 2. Consultant for Biogen Idec and Acorda Therapeutics 3. Funding from Biogen Idec, Acorda Therapeutics, Sun Health Technologies, NMSS, CMSC, and NIH 4. I secretly hope to look this good some day Overview 1. Framework 2. Exercise and Disease Modification 3. Exercise and Symptom Management 4. Participation Rates 5. Prescriptive Guidelines 6. Looking ahead: Next steps 1. FRAMEWORK How Do We Evaluate the Questions? Disease Modification* Progression of disability Relapse rate Neuroimaging metrics Lesion volume ROIs Animal models Symptom Management Functioning Fitness Walking Cognition Symptomology Fatigue Depression QOL *Based on a non-scientific survey of neurologists Can We Evaluate the Questions? How Well? Research Design Cross-sectional Prospective Quasi-experimental RCTs Duration of R x 1° or 2° outcomes Sample Characteristics Disability status Disease course Disease duration DMT or other medication Age/Sex Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.

Upload: others

Post on 15-Oct-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: RobMotl-Keynote PPT · Exercise vs. Other Approaches Depressive Symptoms Ensariet al., J Psychosomatic Res, 2014. Favorable effect of exercise training 2 times larger with PAGs Walking

10/21/2015

1

Exercise and Multiple Sclerosis: Symptom Management or Disease Modification?Robert W. Motl, PhDProfessor, Department of Kinesiology

and Community HealthAffiliate, Neuroscience ProgramChair, Institutional Review Board

Disclosures

1. Speaker’s bureau for EMD Serono

2. Consultant for Biogen Idec and Acorda Therapeutics

3. Funding from Biogen Idec, Acorda

Therapeutics, Sun Health Technologies, NMSS, CMSC, and NIH

4. I secretly hope to look this good some

day

Overview1. Framework

2. Exercise and Disease

Modification

3. Exercise and Symptom Management

4. Participation Rates

5. Prescriptive Guidelines

6. Looking ahead: Next steps 1. FRAMEWORK

How Do We Evaluate the Questions?

Disease Modification*

• Progression of disability

• Relapse rate

• Neuroimaging metrics

– Lesion volume

– ROIs

• Animal models

Symptom Management

• Functioning

– Fitness

– Walking

– Cognition

• Symptomology

– Fatigue

– Depression

• QOL

*Based on a non-scientific survey of neurologists

Can We Evaluate the Questions?How Well?

Research Design

• Cross-sectional

• Prospective

• Quasi-experimental

• RCTs

• Duration of Rx

• 1° or 2° outcomes

Sample Characteristics

• Disability status

• Disease course

• Disease duration

• DMT or other medication

• Age/Sex

Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.

Page 2: RobMotl-Keynote PPT · Exercise vs. Other Approaches Depressive Symptoms Ensariet al., J Psychosomatic Res, 2014. Favorable effect of exercise training 2 times larger with PAGs Walking

10/21/2015

2

2. EVIDENCE -- THE CASE FOR DISEASE MODIFICATION!

This is NOT a New Idea!

PHYSICALACTIVITYAND

Disability Progression

Motl et al, J Neurol Sci, 2012.

Independent of

DMTs

Walking Mobility (i.e., Disability)

Snook & Motl, NNR, 2009.

Favorable effect of exercise training

2 times larger

with supervision Comparable with

effect of DMTs

Relapse -- Systematic Review and Quantification

Pilutti et al., J Neurol Sci, 2014.

RR = .75

25% reduction in

risk

Neuroimaging: T2 Lesion Volume

Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.

Page 3: RobMotl-Keynote PPT · Exercise vs. Other Approaches Depressive Symptoms Ensariet al., J Psychosomatic Res, 2014. Favorable effect of exercise training 2 times larger with PAGs Walking

10/21/2015

3

Neuroimaging: ROIs Neuroimaging: ROIs

How Could Exercise Influence the Brain in MS?

Wrann et al., Cell Metab, 2013.

Cotman & Berchtold, Trends Neurosci, 2002.

Preclinical Research: Exercise and Animal Models

Rossi et al, Neurobiol Dis, 2009.

3. EVIDENCE -- THE CASE FOR SYMPTOM MANAGEMENT!

Aerobic Capacity

• Picture of Test

Platta et al., Med Sci Sports Exerc, 2015.

Favorable effect of

exercise training

Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.

Page 4: RobMotl-Keynote PPT · Exercise vs. Other Approaches Depressive Symptoms Ensariet al., J Psychosomatic Res, 2014. Favorable effect of exercise training 2 times larger with PAGs Walking

10/21/2015

4

Muscle Strength

• Picture of test

Platta et al., Med Sci Sports Exerc, 2015.

Study name Subgroup within study Statistics for each study Hedges's g and 95% CI

Hedges's Standard Lower Upper g error limit limit

Sosnoff et al. combined/ isometric KE (kg) -0.22 0.43 -1.07 0.62

Nilsagard et al. exercise group/timed chair stands -0.08 0.22 -0.52 0.35

Harvey et al. Combined -0.02 0.29 -0.59 0.56

Skjerbaeck et al. handgrip exercise 0.02 0.63 -1.22 1.26

Petajan et al. Combined 0.24 0.09 0.07 0.41

Medina-Perez et al. Combined 0.26 0.17 -0.08 0.59

Dalgas et al. KE MVC (Nm) 0.27 0.36 -0.43 0.98

Dalgas et al Combined 0.35 0.18 -0.00 0.71

Broekmans et al. Combined 0.37 0.17 0.03 0.71

Debolt et al. Leg Ext(power in W/kg and power in W) 0.40 0.34 -0.26 1.06

Surakka et al. Combined 0.40 0.15 0.11 0.69

Fimland et al. max strength training (Nm) 0.69 0.55 -0.39 1.76

Golzari et al. yoga/digital instrument (strength in kg's) 1.15 0.48 0.21 2.10

Learmonth et al. MMT weakest quadriceps strength (Nm) 1.32 1.28 -1.19 3.84

0.27 0.05 0.17 0.38

-2.00 -1.00 0.00 1.00

Favorable effect of strength training

Statistics for each study Hedges's g and 95% CI

Hedges's Standard Lower Upper g error limit limit

-0.22 0.43 -1.07 0.62

-0.08 0.22 -0.52 0.35

-0.02 0.29 -0.59 0.56

0.02 0.63 -1.22 1.26

0.24 0.09 0.07 0.41

0.26 0.17 -0.08 0.59

0.27 0.36 -0.43 0.98

0.35 0.18 -0.00 0.71

0.37 0.17 0.03 0.71

0.40 0.34 -0.26 1.06

0.40 0.15 0.11 0.69

0.69 0.55 -0.39 1.76

1.15 0.48 0.21 2.10

1.32 1.28 -1.19 3.84

0.27 0.05 0.17 0.38

-2.00 -1.00 0.00 1.00 2.00

Favorable effect of strength trainingFavorable effect of

exercise training

Other Outcomes: Cognition and Balance

Symptomatic Fatigue

Pilutti et al., Psychosomatic Med, 2013.

Favorable effect of exercise training

Clinically

Meaningful?

Exercise vs. Other Approaches

Depressive Symptoms

Ensari et al., J Psychosomatic Res, 2014.

Favorable effect of exercise training

2 times larger

with PAGs

Walking Ability

Exercise improves walking endurance and speed

– 2MWT: 12.5 meters father or

19% improvement

– 10mWT: 1.76 seconds faster

or 16.5% improvement*

*Approaches a meaningful

change per stages in Goldman et

al. (2013), Neurology.

Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.

Page 5: RobMotl-Keynote PPT · Exercise vs. Other Approaches Depressive Symptoms Ensariet al., J Psychosomatic Res, 2014. Favorable effect of exercise training 2 times larger with PAGs Walking

10/21/2015

5

Quality of Life

Motl & Gosney, Mult Scler, 2008.

The Real End-

Point, but not a

large change

Other Outcomes

Summarizing and Linking the Pieces Together

Motl & Pilutti, Nat Rev Neurol, 2013.

The Case for

Symptom

Management

The Case for Disease

Modification

4. PARTICIPATION RATES

Overall Physical Activity

The general population is physically inactive (60%)!

Moderate-to-Vigorous Physical Activity

Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.

Page 6: RobMotl-Keynote PPT · Exercise vs. Other Approaches Depressive Symptoms Ensariet al., J Psychosomatic Res, 2014. Favorable effect of exercise training 2 times larger with PAGs Walking

10/21/2015

6

5. PRESCRIPTIVE GUIDELINES

Canadian Guidelines: Process

1. Systematic review as evidence base for guidelines

2. Consensus meeting of panel and unanimous agreement

3. Stakeholder involvement (exercise professionals, physicians, service providers) for rating consistency between evidence and guidelines

4. Additional feedback from adults with MS (N=112), health professionals (N=125), and others (N=28)

5. AGREE II evaluation

Canadian Guidelines: Product

6. LOOKING AHEAD: NEXT STEPS

Direct Comparison with Drug Mechanistic Research

White & Castellano, Sports Med, 2008.

Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.

Page 7: RobMotl-Keynote PPT · Exercise vs. Other Approaches Depressive Symptoms Ensariet al., J Psychosomatic Res, 2014. Favorable effect of exercise training 2 times larger with PAGs Walking

10/21/2015

7

Project VIEWS: Views and Ideas on Exercise among people with MS

NMSS, IL 0017

Project COMPLETe: Coordinate Multiple Sclerosis Exercise Toolkit

Objectives

1. Develop a conceptual

model

2. Develop a tool kit

3. Evaluate the efficacy of the toolkit

Methods

• Qualitative research

– Patients – VIEWS

– Providers – Stage 2

– Model – Stage 3

– Tool kit – Stage 4

• RCT

– Tool kit efficacy – Stage 5

NMSS, Health Care Delivery and

Policy Research mechanisms

Sit Less, Move More! The Health and Wellness Initiative

• 1stmeeting, October,

2014

• 2ndmeeting, October 2015

• Makeover from programs through

research

Acknowledgements

• Participants!

• Undergraduate students, graduate students, post-doctoral

fellows, and colleagues.

• Funding from Mary Jane

Neer Foundation, CMSC, NIH, & NMSS.

Thank you and [email protected]

(217) 265-0886

Website: www.enrl.net

Email: [email protected]

Phone: 888 796-7966

Please purchase 'docPrint PDF Driver' on http://www.verypdf.com/artprint/index.html to remove this message.